Rabies Diagnostics Market

Rabies Diagnostics Market by Diagnostic Methods (Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histological Examination, and Serology Tests), Technology (ELISA/Immunohistochemistry, Chromatography Techniques, PCR, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-842
  • Author: Growth Market Reports
  • Rating: 48.0
  • Total Reviews: 2
  • No. Of Pages: 185
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global rabies diagnostics market size is estimated to expand at a significant CAGR during the forecast period, 2021-2028. The growth of the market is attributed to innovative diagnostic tool for viral infection identification, increasing government initiatives for prevention and eradication of disease, and rising incidence rate of rabies in dense population and low resource regions. Moreover, the increasing research activities for development innovative diagnostics devices related to rabies and rising healthcare expenditure from governments are other key aspects for the market growth.
 

Rabies Diagnostics Market Key Takeaways


Rabies diagnosis is a medical procedure by which pathologist identify the presence of rabies virus either in human or in rabid animal. Direct fluorescent antibody test is most common employed method for diagnosis of rabies in infected animals by detection of antigen exist in brain. Reverse immunohistochemistry test, reverse transcriptase-polymerase chain reaction (RT-PCR), cell culture, intra-vitam process, nucleic acid detection, rapid fluorescent inhibition test, and enzyme linked immunosorbent assays (ELISA) are the most common methods by which medical professionals detect presence of rabies virus in human brain tissue. According to World Health Organization (WHO), 98% of rabies is caused by dog bite, 40% of people including approximately 60,000 deaths every year is related to rabies across the globe.

Rabies, categorized as two groups namely furious rabies and paralytic rabies, are viral disease caused by transmission of virus by animal’s bite such as bats, raccoons, skunks, and foxes infected of rabies virus. The rabies virus contaminates central nervous system of vertebrates that that cause abnormalities in the brain and resulting in death occurred if not provide proper treatment. The common symptoms are muscle pain, dizziness, fatigue, irritation, and anxiety; favipiravir is most commonly used drug for treatment of rabies. The rabies virus is belonging to Mononegavirales order which is non-fragmented, negatively-stranded RNA genomic structure. In this order, viruses are found in bullet shape belonging to Rhabdoviridae family which divided into three genera of animal viruses namely Lyssavirus, Ephemerovirus, and Vesiculovirus. The genus Lyssavirus is further comprising of Lagos bat, Mokola virus, Duvenhage virus, European bat virus, and Rabies virus which are responsible for the infection in animals. Rabies virus constituted by helical ribonucleoprotein core and surrounded by nuclear envelope, made up of five proteins namely nucleoprotein, phosphoprotein, matrix protein, glycoprotein, and polymerase.

Market Trends, Drivers, Restraints, and Opportunities

  • Innovation in diverse diagnostic tools that used for characterization of viral infection along with concluding validation of rabies disease acts as a key driver for the market growth.
  • Introduction of efficient disease regulation programs from government agencies and providing support to elucidate awareness programs for prevention and control of disease are expected to propel the market expansion in the coming years.
  • Rising incidence of rabies in dense populace and low medical facilities area in which this disease is progressively causing death in human and animal. This is another key driver for the market growth.
  • Various global healthcare providers are actively involved in demonstrating research collaboration with biotech firms for the development of advanced diagnostic assays which are contributing to fuel the market growth during the forecast period.
  • At present, laboratories use traditional chemical stain procedure as a diagnostic tool that provide less precise results along with the lack of infrastructure in low-resource areas are the key restraints projected to hinder the market growth in the upcoming years. High price of postexposure prophylaxis (PEP) is another key challenge for the market growth.

Scope of the Report

The report on the global rabies diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Rabies Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Diagnostic Methods (Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histological Examination, and Serology Tests), Technology (ELISA/ Immunohistochemistry,  Chromatography Techniques, PCR, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Bio-Rad Laboratories, Inc.; Aviva Systems Biology Corporation; Merck KGaA; Demeditec Diagnostics GmbH; Creative Diagnostics; Norgen Biotek Corp.; Express Biotech International, Inc.; BIONOTE Co., LTD.; F. Hoffmann-La Roche Ltd.; Agilent Technologies Inc.; Thermo Fisher Scientific, and Qiagen.

 

Global Rabies Diagnostics Market Segment Insights

Fluorescent antibody test segment is expected to grow at a rapid pace
Based on diagnostic methods, the global rabies diagnostics market is divided into fluorescent antibody test (FAT), immunohistochemical test, amplification methods, histological examination, and serology tests. The fluorescent antibody test segment is expected to account for a key share of the market in terms of revenue generation in the coming years due to broad usage and endorsed by WHO for diagnosis. Fluorescent antibody test offers precise results than other traditional approaches contributed to wide utilization of this test, which further propels the segment growth. However, the amplification methods segment is anticipated to expand at a rapid pace during the forecast period due to allowing sensitive test results. Amplification methods allow antemortem and postmortem diagnosis as well as provide sensitive test results along with easy procedure and fast paced diagnosis. These are the major factors that expected to propel the segment growth in the upcoming years.

ELISA/Immunohistochemistry segment is projected to account for a key market share
On the basis of technology, the market is classified into ELISA/immunohistochemistry, chromatography techniques, PCR, and others. The ELISA/immunohistochemistry segment is anticipated to register a robust CAGR during the forecast period due to large perforation of assays. Different diagnostic tests based of ELISA are fluorescent antibody test (FAT), rapid rabies enzyme immunodiagnosis (RREID), direct rapid immunohistochemical test (dRIT), rapid immunodiagnostic test (RIDT), and indirect rapid immunohistochemistry test (IRIT) offer precise results. Diagnostic assays that utilize immunohistochemistry are diversifying benefits that enable higher adoption rate, which in turn, helping to push the segment growth. Immunohistochemistry method use frozen and high shelf-life specimen, offer low-cost diagnosis, use simple light microscope for elucidation of tests, and utilize lesser time. On the other hand, the PCR segment is expected to expand at a rapid pace during the forecast period due to their capacity to analyze antemortem and postmortem rabies diagnosis. Additionally, real-time PCR based approach is a universal method for diagnosis of Lyssavirus.
 

Rabies Diagnostics Market By Technology


Asia Pacific is holding a key market share
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific held a major market share in terms of revenue in 2020 and is estimated to register a significant CAGR share during the forecast period due to increasing incidence of rabies cases and introduction of several government initiatives for various awareness programs for prevention and eradication of disease. On the other hand, North America and Europe in combined is estimated to register a healthy CAGR during the forecast period owing to wide usage of diagnostic test in these regions.
 

Rabies Diagnostics Market By Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Rabies Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Rabies Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Rabies Diagnostics Market - Supply Chain
  4.5. Global Rabies Diagnostics Market Forecast
     4.5.1. Rabies Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Rabies Diagnostics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Rabies Diagnostics Market Absolute $ Opportunity
5. Global Rabies Diagnostics Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Rabies Diagnostics Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Rabies Diagnostics Demand Share Forecast, 2019-2026
6. North America Rabies Diagnostics Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Rabies Diagnostics Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Rabies Diagnostics Demand Share Forecast, 2019-2026
7. Latin America Rabies Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Rabies Diagnostics Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Rabies Diagnostics Demand Share Forecast, 2019-2026
8. Europe Rabies Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Rabies Diagnostics Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Rabies Diagnostics Demand Share Forecast, 2019-2026
9. Asia Pacific Rabies Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Rabies Diagnostics Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Rabies Diagnostics Demand Share Forecast, 2019-2026
10. Middle East & Africa Rabies Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Rabies Diagnostics Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Rabies Diagnostics Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Rabies Diagnostics Market: Market Share Analysis
  11.2. Rabies Diagnostics Distributors and Customers
  11.3. Rabies Diagnostics Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Bio-Rad Laboratories, Inc.
     11.4.2. Aviva Systems Biology Corporation
     11.4.3. Merck KGaA
     11.4.4. Demeditec Diagnostics GmbH
     11.4.5. Creative Diagnostics
     11.4.6. Norgen Biotek Corp.
     11.4.7. Express Biotech International, Inc.
     11.4.8. BIONOTE Co., LTD.
     11.4.9. F. Hoffmann-La Roche Ltd.
     11.4.10. Agilent Technologies

Segments Covered in the Report
The global rabies diagnostics market has been segmented on the basis of

Diagnostic Methods

  • Fluorescent Antibody Test
  • Immunohistochemical Test
  • Amplification methods
  • Histological Examination
  • Serology Tests

Technology

  • ELISA/Immunohistochemistry
  • Chromatography Techniques
  • PCR
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Bio-Rad Laboratories, Inc.
  • Aviva Systems Biology Corporation
  • Merck KGaA
  • Demeditec Diagnostics GmbH
  • Creative Diagnostics
  • Norgen Biotek Corp.
  • Express Biotech International, Inc.
  • BIONOTE Co., LTD.
  • F. Hoffmann-La Roche Ltd.
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific
  • Qiagen

Some of the key players performing in the market are Bio-Rad Laboratories, Inc.; Aviva Systems Biology Corporation; Merck KGaA; Demeditec Diagnostics GmbH; Creative Diagnostics; Norgen Biotek Corp.; Express Biotech International, Inc.; BIONOTE Co., LTD.; F. Hoffmann-La Roche Ltd.; Agilent Technologies Inc.; Thermo Fisher Scientific, and Qiagen. Many of these key players are actively investing in research & development to develop novel biopsy procedures to attain business augmentation that can further contribute to the market growth. Several of these companies are actively engaged in various market strategies such as product launches, mergers, partnerships, acquisitions, and expansion of production units to enhance their market position and expand their consumer base globally.
 

Rabies Diagnostics Market By Key Players

Buy Report